Evidence map›Paper›PMID 41584675›Full record

ArticleFrontiers in plant science2025

Assessing the efficacy of thermotherapy combined with chemotherapy or cryotherapy for the eradication of grapevine leafroll-associated virus 3.

Solomon Peter Wante, Kar Mun Chooi, Ranjith Pathirana, Annabel Whibley, Ellie L Bradley, Yusmiati Liau, Bhanupratap Reddy Vanga, Amy M Hill, Darrell Lizamore

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in plant science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Solomon Peter WanteGrapevine Improvement Laboratory, Bragato Research Institute, Lincoln, New Zealand.
Kar Mun ChooiPlant Pathogen Environment, New Zealand Institute for Bioeconomy Science Limited, Mt Albert, Auckland, New Zealand.
Ranjith PathiranaSchool of Agriculture, Food and Wine, University of Adelaide, Adelaide, SA, Australia.
Annabel WhibleyGrapevine Improvement Laboratory, Bragato Research Institute, Lincoln, New Zealand.
Ellie L BradleyGrapevine Improvement Laboratory, Bragato Research Institute, Lincoln, New Zealand.
Yusmiati LiauGrapevine Improvement Laboratory, Bragato Research Institute, Lincoln, New Zealand.
Bhanupratap Reddy VangaGrapevine Improvement Laboratory, Bragato Research Institute, Lincoln, New Zealand.
Amy M HillGrapevine Improvement Laboratory, Bragato Research Institute, Lincoln, New Zealand.
Darrell LizamoreGrapevine Improvement Laboratory, Bragato Research Institute, Lincoln, New Zealand.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Grapevine leafroll-associated virus 3 (GLRaV-3) poses a significant threat to viticulture and is the major virus pathogen in New Zealand. The presence of the virus is therefore undesirable within the New Zealand Winegrowers National Vine Collection, which serves as a repository of diverse and valuable grapevine genotypes. Methods: This study evaluated the effectiveness of Results: Thermotherapy followed by cryotherapy achieved the highest virus elimination rates across cultivars, including complete eradication in Sauvignon Blanc 217, Chenin Blanc, and Riesling Gm 239. Oseltamivir chemotherapy combined with thermotherapy showed higher elimination rates than ribavirin-based treatments, with complete success in Ehrenfelser and Golden Chasselas. Discussion: Cultivar-specific responses emphasise the need to optimise treatment protocols to achieve broad efficacy across diverse cultivars. After virus elimination, tissue-cultured material could be maintained

Indexed as

grapevineleafroll virusoseltamivirribavirintissue culturevirus elimination

Identifiers

PMID41584675
PMCPMC12826072

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.